Deborah F. Chapman

1.1k total citations
13 papers, 933 citations indexed

About

Deborah F. Chapman is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Epidemiology. According to data from OpenAlex, Deborah F. Chapman has authored 13 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Deborah F. Chapman's work include Neuroscience and Neuropharmacology Research (8 papers), Acute Ischemic Stroke Management (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Deborah F. Chapman is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Acute Ischemic Stroke Management (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Deborah F. Chapman collaborates with scholars based in United States. Deborah F. Chapman's co-authors include Paul A. Lapchak, Justin A. Zivin, Nicholas D. P. Cosford, Margaret Bradbury, Mark A. Varney, Jeffery J. Anderson, Chris King, Lida Tehrani, Jeffrey Roppe and Sara Rao and has published in prestigious journals such as Stroke, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Deborah F. Chapman

13 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah F. Chapman United States	11	348	339	253	126	122	13	933
Wilson B. Chwang United States	9	177 0.5×	484 1.4×	69 0.3×	158 1.3×	125 1.0×	12	888
Shangfeng Gao China	23	248 0.7×	654 1.9×	66 0.3×	214 1.7×	56 0.5×	64	1.3k
Stephanie J. Fischer United States	10	294 0.8×	370 1.1×	66 0.3×	81 0.6×	29 0.2×	10	1.0k
Koh Kawasaki Japan	14	199 0.6×	403 1.2×	69 0.3×	65 0.5×	129 1.1×	24	924
Qi-Huang Zheng United States	26	327 0.9×	681 2.0×	60 0.2×	236 1.9×	107 0.9×	93	1.9k
Swetlana Sperling Germany	15	109 0.3×	246 0.7×	58 0.2×	56 0.4×	140 1.1×	25	913
Ping He United States	24	311 0.9×	1.0k 3.1×	69 0.3×	288 2.3×	110 0.9×	51	1.8k
Jerry P. Melchor United States	17	311 0.9×	634 1.9×	112 0.4×	223 1.8×	215 1.8×	22	1.7k
Tianhong Pan United States	19	222 0.6×	759 2.2×	125 0.5×	504 4.0×	251 2.1×	29	1.5k
Márta Zarándi United States	28	213 0.6×	717 2.1×	148 0.6×	179 1.4×	108 0.9×	67	2.0k

Countries citing papers authored by Deborah F. Chapman

Since Specialization

Citations

This map shows the geographic impact of Deborah F. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah F. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah F. Chapman more than expected).

Fields of papers citing papers by Deborah F. Chapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah F. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah F. Chapman. The network helps show where Deborah F. Chapman may publish in the future.

Co-authorship network of co-authors of Deborah F. Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah F. Chapman. A scholar is included among the top collaborators of Deborah F. Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah F. Chapman. Deborah F. Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Tehrani, Lida, Nicholas D. Smith, Dehua Huang, et al.. (2005). 3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: Identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(22). 5061–5064. 10 indexed citations

Bradbury, Margaret, Una C. Campbell, Deborah F. Chapman, et al.. (2005). Metabotropic Glutamate Receptor mGlu5 Is a Mediator of Appetite and Energy Balance in Rats and Mice. Journal of Pharmacology and Experimental Therapeutics. 313(1). 395–402. 75 indexed citations

Huang, Dehua, Steve F. Poon, Deborah F. Chapman, et al.. (2005). 2‐{2‐[3‐(Pyridin‐3‐yloxy)phenyl]‐2H‐tetrazol‐5‐yl}pyridine: A Highly Potent, Orally Active, Metabotropic Glutamate Subtype 5 (mGlu5) Receptor Antagonist.. ChemInform. 36(14). 1 indexed citations

Poon, Steve F., Brian Eastman, Deborah F. Chapman, et al.. (2004). 3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 14(22). 5477–5480. 19 indexed citations

Huang, Dehua, Steve F. Poon, Deborah F. Chapman, et al.. (2004). 2-{2-[3-(Pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl}pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 14(22). 5473–5476. 25 indexed citations

Bradbury, Margaret, et al.. (2003). Metabotropic glutamate receptor 5 antagonist-induced stimulation of hypothalamic–pituitary–adrenal axis activity: interaction with serotonergic systems. Neuropharmacology. 44(5). 562–572. 43 indexed citations

Anderson, Jeffery J., Margaret Bradbury, Deborah F. Chapman, et al.. (2003). In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine). European Journal of Pharmacology. 473(1). 35–40. 124 indexed citations

Anderson, Jeffery J., Sara Rao, Blake A. Rowe, et al.. (2002). [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization. Journal of Pharmacology and Experimental Therapeutics. 303(3). 1044–1051. 93 indexed citations

Lapchak, Paul A., Deborah F. Chapman, & Justin A. Zivin. (2001). Pharmacological Effects of the Spin Trap AgentsN-t-Butyl-Phenylnitrone (PBN) and 2,2,6,6-Tetramethylpiperidine-N-Oxyl (TEMPO) in a Rabbit Thromboembolic Stroke Model. Stroke. 32(1). 147–153. 57 indexed citations

10.

Chapman, Deborah F., et al.. (2001). Comparison of TNK With Wild-Type Tissue Plasminogen Activator in a Rabbit Embolic Stroke Model. Stroke. 32(3). 748–752. 44 indexed citations

11.

Lapchak, Paul A., et al.. (2000). Dehydroepiandrosterone Sulfate Is Neuroprotective in a Reversible Spinal Cord Ischemia Model. Stroke. 31(8). 1953–1957. 98 indexed citations

12.

Lapchak, Paul A., Deborah F. Chapman, & Justin A. Zivin. (2000). Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke. Stroke. 31(12). 3034–3040. 275 indexed citations

13.

Petty, M. M., et al.. (1995). Relationships between Organizational Culture and Organizational Performance. Psychological Reports. 76(2). 483–492. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact